STOCK TITAN

Merit Medical Systems Inc - MMSI STOCK NEWS

Welcome to our dedicated page for Merit Medical Systems news (Ticker: MMSI), a resource for investors and traders seeking the latest updates and insights on Merit Medical Systems stock.

Merit Medical Systems Inc (NASDAQ: MMSI) is a leading manufacturer of medical devices used in diagnostic and interventional cardiology, radiology, and endoscopy procedures. Headquartered in South Jordan, Utah, the company employs approximately 7,000 individuals globally. Merit Medical's extensive product portfolio includes inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, guide wires, thrombolytic catheters, fluid dispensing systems, angiography accessories, and custom angiography kits. The company's products are marketed across the United States, Europe, and around the world through direct sales forces and distributors.

Merit Medical operates primarily in two segments: Cardiovascular, which constitutes the majority of its revenue, and Endoscopy. The company is renowned for its innovative healthcare technology, with recent notable achievements including FDA 510(k) clearance for their SCOUT® MD™ Surgical Guidance System, designed to enhance the precision of tumor excision in breast cancer surgeries.

In 2024, Merit Medical commenced the MOTION study, a multicenter, prospective, randomized, controlled trial comparing genicular artery embolization (GAE) using Embosphere® Microspheres to corticosteroid injections for treating knee osteoarthritis. This study underscores the company's commitment to evidence-based medicine and patient-centric care. Additionally, the company recently launched the Micro ACE Advanced Micro-Access System and the Siege Vascular Plug, which are expected to significantly improve patient outcomes in vascular procedures.

Financially, the company has introduced a Continued Growth Initiatives Program with robust targets set for 2026. Merit Medical has consistently focused on innovation, investment in research, and strategic expansion, making it a pivotal player in the medical technology sector.

For the latest updates and detailed financial data, Merit Medical Systems regularly schedules earnings calls and provides comprehensive reports which can be accessed by interested stakeholders.

Rhea-AI Summary
Merit Medical Systems, Inc. (Nasdaq: MMSI) plans to offer $550.0 million aggregate principal amount of Convertible Senior Notes due 2029 in a private placement. The notes will be senior unsecured obligations, with interest payable semiannually in arrears, and will be convertible to cash, shares of Merit's common stock, or a combination of both. The company intends to use the net proceeds for general corporate purposes, including repayment of existing debt, sales and marketing activities, research and development, and potential acquisitions. Merit also plans to enter into capped call transactions to reduce potential dilution to its common stock upon conversion of notes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.37%
Tags
none
-
Rhea-AI Summary
Merit Medical Systems reports Q3 2023 revenue of $315.2 million, up 9.8% YoY. Raises fiscal year 2023 financial guidance. GAAP operating margin increases to 11.1% in Q3 2023. Non-GAAP operating margin increases to 18.3% in Q3 2023. GAAP EPS increases to $0.44 in Q3 2023. Non-GAAP EPS increases to $0.75 in Q3 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.68%
Tags
-
Rhea-AI Summary
Merit Medical Systems expands Maestro Microcatheter product line with new longer length for radial embolization procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
Rhea-AI Summary
Merit Medical Systems, Inc. to release Q3 2023 financial results on October 26, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
-
Rhea-AI Summary
Merit Medical Systems, Inc. announces the U.S. commercial release of its Aspira Bottle, expanding its drainage portfolio. The bottle offers a compassionate at-home treatment option for patients with pleural effusions and malignant ascites. The advanced design requires 23% less storage space and allows users to control drainage speed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.36%
Tags
none
-
Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study, comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) to percutaneous transluminal angioplasty for the treatment of stenosis/occlusion in the venous outflow circuit in patients undergoing hemodialysis. The study enrolled 244 patients with AVFs and 113 patients with AVGs across multiple countries. Merit intends to file primary outcomes with the FDA for Premarket Approval after six months post-enrollment completion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.08%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
none

FAQ

What is the current stock price of Merit Medical Systems (MMSI)?

The current stock price of Merit Medical Systems (MMSI) is $103.67 as of January 23, 2025.

What is the market cap of Merit Medical Systems (MMSI)?

The market cap of Merit Medical Systems (MMSI) is approximately 6.0B.

What does Merit Medical Systems Inc specialize in?

Merit Medical Systems Inc specializes in manufacturing medical devices for diagnostic and interventional cardiology, radiology, and endoscopy procedures.

Where is Merit Medical Systems headquartered?

Merit Medical Systems is headquartered in South Jordan, Utah, a suburb of Salt Lake City.

What are the main product segments of Merit Medical Systems?

The main product segments of Merit Medical Systems are Cardiovascular and Endoscopy, with the majority of revenue generated from the Cardiovascular segment.

What recent study has Merit Medical initiated?

Merit Medical has initiated the MOTION study, comparing genicular artery embolization using Embosphere® Microspheres to corticosteroid injections for knee osteoarthritis treatment.

What is the SCOUT® MD™ Surgical Guidance System?

The SCOUT® MD™ Surgical Guidance System is a newly FDA-cleared product designed to enhance the precision of tumor excision in breast cancer surgeries.

How does Merit Medical distribute its products?

Merit Medical distributes its products through a direct sales force in the United States and Europe and through distributors globally.

What is the significance of the Micro ACE Advanced Micro-Access System?

The Micro ACE Advanced Micro-Access System is an innovative device designed to achieve micro-access in a wide range of vascular anatomies, enhancing patient care in interventional procedures.

What is the Siege Vascular Plug used for?

The Siege Vascular Plug is used for embolization, a minimally invasive procedure to occlude blood vessels, and is designed for precise placement and rapid vessel occlusion.

What is Merit Medical's employment size?

Merit Medical employs approximately 7,000 individuals worldwide.

What are some of the financial initiatives of Merit Medical?

Merit Medical has launched a Continued Growth Initiatives Program and has set ambitious financial targets for 2026, focusing on organic revenue growth and operating margin improvements.
Merit Medical Systems Inc

Nasdaq:MMSI

MMSI Rankings

MMSI Stock Data

5.99B
56.84M
2.48%
104.4%
4.41%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
SOUTH JORDAN